Ergomed Clinical Leader Solutions Expo May 2025: CRO Services – Oncology

The right partner makes a difference.

The number of innovative investigational oncology agents is rapidly increasing, offering promising advancements in patient outcomes. However, this progress also brings intensified competition for clinical trials sites, their resources and patient access. Given the aggressive nature of many cancers and their severe symptom burden, the window for initiating treatment is often short, requiring timely and well-informed decisions by oncologists. Supporting investigators and trials sites effectively becomes critical to ensuring study success.

To optimize trial execution in this complex environment, several strategic elements should be considered:

• Study Positioning and Scientific Engagement
• Identifying the Right Sites
• Efficient Country Strategy
• Reducing Site Burden
• Patient Burden Analysis

By combining strategic foresight with hands-on support, the right partner accelerates oncology trial delivery and broadens access to promising therapies.